Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial
纳武利尤单抗联合化疗一线治疗转移性非小细胞肺癌:III期CheckMate 227第二部分试验结果
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2023.102065
Borghaei, H; O'Byrne, K J; Paz-Ares, L; Ciuleanu, T-E; Yu, X; Pluzanski, A; Nagrial, A; Havel, L; Kowalyszyn, R D; Valette, C A; Brahmer, J R; Reck, M; Ramalingam, S S; Zhang, L; Ntambwe, I; Rabindran, S K; Nathan, F E; Balli, D; Wu, Y-L